Guosheng Ding

Papers

Total Citations

H-Index

About

Dr. Guosheng Ding is a clinician-scientist whose research focuses on the intersection of oxidative stress, metabolic biomarkers, and surgical oncology, particularly in hepatitis B-related liver cancer. His most cited work investigates the clinical significance of serum oxidative stress and uric acid levels as preoperative prognostic indicators for patients undergoing surgery for hepatitis B-related hepatocellular carcinoma. This study, published in 2023 and garnering 6 citations, highlights his contribution to identifying accessible biomarkers that could improve risk stratification and surgical outcomes. Beyond this, Dr. Ding has explored the intraoperative use of indocyanine green (ICG) fluorescence imaging—a minimally toxic, water-soluble dye—to enhance anatomical identification, assess organ perfusion, map biliary structures, and evaluate anastomosis integrity during gastrointestinal surgery. His work bridges metabolic pathophysiology with practical surgical innovations, aiming to refine both preoperative assessment and intraoperative decision-making. While his citation impact is still growing, Dr. Ding’s research addresses critical gaps in personalized surgical care for liver cancer patients, offering potential for improved prognosis and safer procedures. His contributions are particularly relevant for researchers and clinicians interested in biomarker-driven surgical oncology and fluorescence-guided surgery.